ValiRx plc (LON:VAL – Get Free Report) dropped 1.4% on Friday . The company traded as low as GBX 0.34 and last traded at GBX 0.36. Approximately 4,393,784 shares were traded during mid-day trading, a decline of 38% from the average daily volume of 7,117,977 shares. The stock had previously closed at GBX 0.37.
ValiRx Stock Down 6.8%
The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.27 and a current ratio of 6.65. The firm’s 50-day simple moving average is GBX 0.37 and its 200 day simple moving average is GBX 0.52. The company has a market cap of £2.53 million, a P/E ratio of -0.37 and a beta of 0.59.
ValiRx (LON:VAL – Get Free Report) last issued its earnings results on Monday, September 29th. The company reported GBX (0.22) earnings per share (EPS) for the quarter. ValiRx had a negative net margin of 20,554.01% and a negative return on equity of 55.84%. On average, research analysts forecast that ValiRx plc will post -1.74 earnings per share for the current fiscal year.
About ValiRx
ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.
See Also
- Five stocks we like better than ValiRx
- There Are Different Types of Stock To Invest In
- Disney’s $1 Billion Deal Brings Its Magic to OpenAI
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Why Amazon Could Be a $300 Stock Within Weeks
- Insider Buying Explained: What Investors Need to Know
- Adobe Gets Post-Earnings Lift: Long-Term Outlook Favors Upside
Receive News & Ratings for ValiRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ValiRx and related companies with MarketBeat.com's FREE daily email newsletter.
